Mutations in the X-linked PLP1-gene (encoding PLP and its smaller isoform DM20) lead to dysmyelinating disease with a broad clinical spectrum, ranging from severe Pelizaeus–Merzbacher disease (PMD) to milder spastic paraplegia type 2 (SPG-2). Here, PLP1 is linked to Spastic paraplegia type 2.